Beutel, Goodman & Co’s Medtronic MDT Stock Holding History

Beutel, Goodman & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$316M	Sell	3,662,088 -260,188	-7%	-$22.9M	2.49%	7
2026 Q2	$307M	Sell	3,922,276 -546,898	-12%	-$44.1M	2.26%	9
2026 Q1	$387M	Sell	4,469,174 -262,437	-6%	-$25.1M	2.63%	7
2025 Q4	$455M	Sell	4,731,611 -33,494	-0.7%	-$3.25M	2.79%	5
2025 Q3	$454M	Sell	4,765,105 -142,161	-3%	-$13.1M	2.73%	4
2025 Q2	$428M	Buy	4,907,266 +115,209	+2%	+$9.8M	2.44%	9
2025 Q1	$431M	Buy	4,792,057 +70,357	+1%	+$6.3M	2.48%	9
2024 Q4	$377M	Buy	+4,721,700	New	+$409M	2.05%	15
2018 Q1	–	Sell	-605	Closed	-$39K	–	72
2017 Q4	$39K	Buy	+605	New	+$48.5K	﹤0.01%	70

Other funds holding MDT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Beutel, Goodman & Co's MDT Position: Q3 2026 in Review

Beutel, Goodman & Co reduced its Medtronic (MDT) stake by 6.6% in Q3 2026, selling an estimated $22.9M and leaving 3,662,088 shares worth $316M. The position accounts for 2.49% of the portfolio, ranked #7.

Beutel, Goodman & Co first reported a position in MDT in Q4 2017 and has held it in 9 quarters since. The position peaked at $455M in Q4 2025. 1,374 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

Beutel, Goodman & Co held 3,662,088 shares of Medtronic worth $316M as of Q3 2026.
Beutel, Goodman & Co sold 260,188 Medtronic shares in Q3 2026, an estimated $22.9M.
Medtronic made up 2.49% of Beutel, Goodman & Co's portfolio in Q3 2026, its #7 holding.
Beutel, Goodman & Co first reported a position in Medtronic in Q4 2017 and has held it in 9 quarters since.
Beutel, Goodman & Co's Medtronic position peaked at $455M in Q4 2025.
1,374 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Beutel, Goodman & Co's 13F filing for Q3 2026, filed 4 Nov 2026.